BioSpace News Archive

On March 19, the 2019-nCoV Detection Kit and Nucleic Acid Extraction Donation & Shipment Ceremony was held in Beijing.

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) today provided an update on its 2016 collaboration agreement with Celgene Corporation, a wholly owned subsidiary of Bristol Myers Squibb Company.

Grifols announces that it has entered into a formal collaboration with the US Biomedical Advanced Research Development Authority, the FDA and other Federal public health agencies to collect plasma from convalescent COVID-19 patients, process this specific plasma into a hyperimmune globulin and support the necessary preclinical and clinical studies to determine if anti-SARS-CoV-2 hyperimmune globulin therapy can successfully be used to treat COVID-19 disease.

The Prime Minister will address Canadians on the COVID-19 situation, and a media availability will follow.

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a life sciences company focused on the research and development of therapeutics for rare disorders and infectious diseases, is pleased to announce that the Company has retained Pharm-Olam, LLC,

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced that it will report its Fourth Quarter and full Fiscal Year 2019 financial results after the close of market on March 30, 2020.

Company’s Leap-In Transposase® platform enables the rapid large-scale production of proteins critical to the development of diagnostics, vaccines and therapeutics

The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic